Movement Disorders

Clinical Research


fact_group

 

If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@ucdenver.edu

 

Parkinson's Disease

COMIRB #Title (Please click on the title to see approved advertisement)Principal InvestigatorEligibility and InformationAdvertisement
17-2318A randomized, double blind, placebo-controlled parallel study of tolerability and efficacy of Cannabidiol (CBD) on motor symptoms in Parkinson’s diseaseLeehey, Maureen A., MDClinical TrialsSee Advertisement
16-2308Neurologic Music Therapy for enhancing fine motor control in Parkinson’s DiseaseIsabelle Buard, PhDClinical TrialsSee Advertisement
18-1356Peripheral Inflammatory Cytokine and Alpha Synuclein Levels in Parkinson Disease and Essential TremorLeehey, Maureen A., MDN/AN/A
18-0829A Randomized, Placebo Surgery Controlled, Double-blinded, Multi-center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of VY-AADC02 in Advanced Parkinson’s Disease with Motor FluctuationsKern, Drew, MD, MSClinical TrialsN/A
18-2047A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 with Immediate-Release Carbidopa-Levodopa in Parkinson’s Disease PatientsFullard, Michelle, MD, MSCEClinical TrialsSee Advertisement
19-0414A Phase 3, 4-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic FailureHawkins, Trevor H., MDClinical TrialsN/A
19-0520A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD˗9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic FailureHawkins, Trevor H., MDClinical TrialsN/A
19-0478A 14-Week, Double-Blind, Randomized, Three-Arm, Parallel Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine versus Placebo for the Treatment of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease (gLIDe)Hawkins, Trevor H., MDClinical TrialsSee Advertisement
19-1405Engaging the Denver Hispanic Community in Parkinson's Disease ResearchFullard, Michelle, MD, MSCEN/ASee Advertisement
19-2471Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinson’s DiseaseLeehey, Maureen A., MDClinical TrialsN/A
19-0865A Multi-center, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease (PD)Berman, Brian D.,MD, MSClinical TrialsSee Advertisement

 

Huntington's Disease

COMIRB #Title (Please click on the title to see approved advertisement)Principal InvestigatorEligibility and InformationAdvertisement
16-2308Neurologic Music Therapy for enhancing fine motor control in Parkinson’s Disease and Other Basal Ganglia DisordersIsabelle Buard, PhDN/ASee Advertisement
18-0216Perceived Palliative Care Needs in Huntington DiseaseBrooke Heffernan, MDN/ASee Advertisement
19-1840A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated with Huntington DiseaseSeeberger, Lauren C., MDClinical TrialsN/A

 

Dystonia

COMIRB #Title (Please click on the title to see approved advertisement)Principal InvestigatorEligibility and InformationAdvertisement
17-1322Transcranial electrical stimulation for the treatment of focal dystoniaBerman, Brian D., MD, MSN/AN/A
11-0647Project 1: Natural History and Biospecimen Repository for DystoniaBerman, Brian D., MD, MSClinical TrialsN/A

 

Ataxia

COMIRB #Title (Please click on the title to see approved advertisement)Principal InvestigatorEligibility and InformationAdvertisement
18-0020Clinical Trial Readiness for SCA1 and SCA3Seeberger, Lauren C., MDClinical TrialsSee Advertisement
18-1875A Phase III, Long-Term, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects with Spinocerebellar AtaxiaSeeberger, Lauren C., MDClinical TrialsSee Advertisement
18-1641Clinical Outcome Measures in Friedreich’s AtaxiaSeeberger, Lauren C., MDClinical TrialsN/A

 

Healthy Volunteer

COMIRB #Title (Please click on the title to see approved advertisement)Principal InvestigatorEligibility and InformationAdvertisement
19-1251Gamma band neural stimulation and its effects on resting state networksBerman, Brian D., MD, MSN/AN/A
18-1356Peripheral Inflammatory Cytokine and Alpha Synuclein Levels in Parkinson Disease and Essential TremorLeehey, Maureen A., MDN/AN/A